BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30763525)

  • 1. A comprehensive review of hormonal and biological therapies for endometriosis: latest developments.
    Barra F; Grandi G; Tantari M; Scala C; Facchinetti F; Ferrero S
    Expert Opin Biol Ther; 2019 Apr; 19(4):343-360. PubMed ID: 30763525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigational drugs for the treatment of endometriosis, an update on recent developments.
    Barra F; Scala C; Mais V; Guerriero S; Ferrero S
    Expert Opin Investig Drugs; 2018 May; 27(5):445-458. PubMed ID: 29708812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and emerging treatment options for endometriosis.
    Ferrero S; Evangelisti G; Barra F
    Expert Opin Pharmacother; 2018 Jul; 19(10):1109-1125. PubMed ID: 29975553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and Emerging Therapeutics for the Management of Endometriosis.
    Ferrero S; Barra F; Leone Roberti Maggiore U
    Drugs; 2018 Jul; 78(10):995-1012. PubMed ID: 29946962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in pharmacotherapy for treating endometriosis.
    Tafi E; Leone Roberti Maggiore U; Alessandri F; Bogliolo S; Gardella B; Vellone VG; Grillo F; Mastracci L; Ferrero S
    Expert Opin Pharmacother; 2015; 16(16):2465-83. PubMed ID: 26569155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of phase II and III drugs for the treatment and management of endometriosis.
    Perrone U; Evangelisti G; Laganà AS; Bogliolo S; Ceccaroni M; Izzotti A; Gustavino C; Ferrero S; Barra F
    Expert Opin Emerg Drugs; 2023 Dec; 28(4):333-351. PubMed ID: 38099328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of early drug development for endometriosis.
    Leone Roberti Maggiore U; Ferrero S
    Expert Opin Investig Drugs; 2016; 25(2):227-47. PubMed ID: 26619754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elagolix sodium for the treatment of women with moderate to severe endometriosis-associated pain.
    Barra F; Scala C; Ferrero S
    Drugs Today (Barc); 2019 Apr; 55(4):237-246. PubMed ID: 31050692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of pharmacotherapy in the treatment of endometriosis across the lifespan.
    Schwartz K; Llarena NC; Rehmer JM; Richards EG; Falcone T
    Expert Opin Pharmacother; 2020 Jun; 21(8):893-903. PubMed ID: 32164462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of medical treatment of endometriosis.
    Martone S; Troìa L; Marcolongo P; Luisi S
    Minerva Obstet Gynecol; 2021 Jun; 73(3):304-316. PubMed ID: 34008385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elagolix for endometriosis: all that glitters is not gold.
    Vercellini P; Viganò P; Barbara G; Buggio L; Somigliana E;
    Hum Reprod; 2019 Feb; 34(2):193-199. PubMed ID: 30551159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of elagolix in the treatment of endometriosis.
    Perricos A; Wenzl R
    Expert Opin Pharmacother; 2017 Sep; 18(13):1391-1397. PubMed ID: 28737050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal therapy for endometriosis: from molecular research to bedside.
    Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of elagolix for the treatment of endometriosis.
    Melis GB; Neri M; Corda V; Malune ME; Piras B; Pirarba S; Guerriero S; Orrù M; D'Alterio MN; Angioni S; Paoletti AM
    Expert Opin Drug Metab Toxicol; 2016 May; 12(5):581-8. PubMed ID: 27021205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pain associated with deep endometriosis: alternatives and evidence.
    Ferrero S; Alessandri F; Racca A; Leone Roberti Maggiore U
    Fertil Steril; 2015 Oct; 104(4):771-792. PubMed ID: 26363387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elagolix, a novel, orally bioavailable GnRH antagonist under investigation for the treatment of endometriosis-related pain.
    Ezzati M; Carr BR
    Womens Health (Lond); 2015 Jan; 11(1):19-28. PubMed ID: 25581052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatments for endometriosis-associated pelvic pain.
    Zito G; Luppi S; Giolo E; Martinelli M; Venturin I; Di Lorenzo G; Ricci G
    Biomed Res Int; 2014; 2014():191967. PubMed ID: 25165691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research development of a new GnRH antagonist (Elagolix) for the treatment of endometriosis: a review of the literature.
    Alessandro P; Luigi N; Felice S; Maria PA; Benedetto MG; Stefano A
    Arch Gynecol Obstet; 2017 Apr; 295(4):827-832. PubMed ID: 28255765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].
    Legendre G; Delbos L; Hudon E; Chabbert-Buffet N; Geoffron S; Sauvan M; Fernandez H; Bouet PE; Descamps P
    Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):256-263. PubMed ID: 29530558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.